Neogen Corporation has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants.

The  BioLumix business will be consolidated with Neogen's closely related Soleris®  technology, which is widely used for the detection of spoilage organisms in  several food industries, as well as the nutraceutical market. The Soleris  system was the first in the industry used for the detection of microbial  contamination based upon an innovative application of well-accepted classical  microbiology.

"Combining  of the Soleris and BioLumix technologies, market bases, and outstanding  technical staffs will greatly enhance both businesses and offer significant  labor saving rapid solutions for the food, pharmaceutical, and personal care  businesses," said James Herbert, Neogen's chief executive officer and chairman.  "The combination also settles litigation of seven years between the two  companies, and benefits existing customers of both companies moving forward."

Terms  of the agreement were not disclosed.